All

× UPDATE! Updated as of 19 April 2024.
Records 1 to 20 of 32258
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-041-03 Enoxaparin Sodium Enoxbicare-40 4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL Solution For Injection (SC) Prescription Drug (Rx) - Brawn Laboratories Ltd. India Initial (Revalidation) 25 April 2022 09 December 2025
View BR-088 Enoxaparin Sodium Hepaclex 60 mg/0.6 mL Solution for Injection (SC) Prescription Drug (Rx) Antithrombotic Agents Gland Pharma Limited India Renewal 07 March 2024 04 June 2028
View BR-1000 Japanese Encephalitis Virus (Live, Attenuated) Imojev Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus. Powder for Suspension for Injection (SC) Prescription Drug (RX) - Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd. Thailand Initial (Variation) 13 July 2022 13 July 2027
View BR-1001 Phospholipid Fraction from Bovine Lung Alveofact 45 mg/mL (54 mg/1.2 mL) Lyophilized Powder for Suspension for Intratracheal Administration Prescription Drug (RX) - BAG Health Care GmbH Germany - 11 May 2021 06 January 2025
View BR-1008 Human Insulin (rDNA) Actrapid 100 IU/mL Solution For Injection (Im/Iv/Sc) Prescription Drug (RX) Antidiabetic Novo Nordisk A/S Denmark Renewal 05 April 2024 06 May 2029
View BR-1009 Insulin Human Insulatard Flexpen 100 U/mL Suspension For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark Regular Renewal 08 March 2021 13 August 2025
View BR-1010 Isophane Insulin Human, Recombinant DNA Insulatard 100 IU/mL Suspension For Injection Prescription Drug (RX) Intermediate-acting Insulin Novo Nordisk A/S Denmark Renewal 02 August 2023 20 August 2028
View BR-1011 Insulin Detemir Levemir FlexPen 100 U/ mL Solution for injection Prescription Drug (Rx) Antidiabetic Novo Nordisk A/S Denmark Automatic Renewal 03 February 2022 22 December 2026
View BR-1012 Insulin Human Mixtard 30 FlexPen 100 IU/mL (Soluble Insulin 30% and Isophane Insulin 70%) Suspension For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 08 March 2021 25 August 2025
View BR-1013 Somatropin Norditropin SimpleXx 5 mg / 1.5 mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 19 April 2021 15 November 2025
View BR-1014 Biphasic Insulin Aspart 30 NovoMix 30 FlexPen 100 IU/ mL Suspension for injection (SC) Prescription Drug (Rx) Antidiabetic Novo Nordisk A/S Denmark Automatic Renewal 01 February 2022 21 December 2026
View BR-1015 Insulin Aspart NovoRapid Flexpen 100 IU/ mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 08 March 2021 13 August 2025
View BR-1016 Liraglutide Victoza 6mg/mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 26 November 2021 07 February 2026
View BR-1018 Darbepoetin Alfa Nesp 20mcg/0.5mL Solution For Injection (I.V. / S.C.) Prescription Drug (RX) - Terumo Corporation (Kofu Factory) Japan Initial 09 October 2020 26 January 2025
View BR-1019 Darbepoetin Alfa Nesp 30mcg/0.5mL Solution For Injection (I.V. / S.C.) Prescription Drug (RX) - Terumo Corporation (Kofu Factory) Japan Initial 09 October 2020 26 January 2025
View BR-1020 Darbepoetin Alfa Nesp 40mcg/0.5mL Solution For Injection (I.V./S.C.) Prescription Drug (RX) - Terumo Corporation (Kofu Factory) Japan Initial 09 October 2020 26 January 2025
View BR-1025 Tetanus Toxoid Adsorbed None 40 iu / 0.5mL Suspension for Injection (IM) Prescription Drug (RX) - Biological E. Limited India - 06 March 2020 28 January 2025
View BR-1026 Laronidase Aldurazyme 580 mcg/mL (2.9 mg/5 mL) Concentrated Solution for IV Infusion Prescription Drug (RX) - Biomarin Pharmaceutical Inc. U.S.A - 22 March 2022 29 September 2026
View BR-1045 Idursulfase Elaprase 6 mg/3 mL (2 mg/mL) Concentrate for Solution for Infusion (IV) Prescription Drug (Rx) Enzymes Vetter Pharma-Fertigung GmbH & Co. KG Germany Renewal 20 March 2024 09 December 2028
View BR-1046 Insulin Glulisine Apidra 3.49 mg/mL (equivalent to 100 Units/mL) Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection Prescription Drug (RX) - Sanofi-Aventis Deutschland GmbH Germany - 26 February 2021 28 October 2025